A Note to the Drug Development Community, From a Patient’s Perspective
The daily grind of getting a drug to clinical trial is grueling. When one is lost in the midst of seemingly never-ending paperwork, obstacles, and deadlines, the stress can pile on. Getting a drug to market is a marathon, not a sprint - but
Read More
NO SURPRISE Here: Brexit causing uncertainty for clinical supply
July 27, 2017
This week's blog post will focus on the uncertainty that Brexit brings to the clinical supply field. One of our upcoming Sherpa Summer Seminar speakers, John Shillingford, PhD, Independent Consultant, was kind enough to blog about
Read More
The EU Qualified Person and clinical supplies – what’s all the fuss about?
July 17, 2017
We’re going to kick off our blog with a focus on the Qualified Person (QP) process, as we get a lot of questions on this.
Read More